{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Chronic Heart Failure: A Pharmacologic Review

Activity Steps

Description

This article has been approved by the Orthopaedic Nurses Certification Board for Category B credit toward recertification as an ONC.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Select a major risk factor for the development of HF.
  2. Identify goals of pharmacologic and non-pharmacologic treatments for HF.
  3. Describe potential adverse effects of pharmacologic therapies for HF.
  4. Identify therapeutic effects of selected medications to treat HF.
Price: $20.00

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: ON0922C-CT
Published: Sep/Oct 2022
Expires: 9/5/2025
Required Passing Score: 8/10 (80%)
Authors: Shereen Salama, PharmD; Aeman Choudhury, PharmD, BCPS, BCACP; Sean P. Kane, PharmD, BCPS
Categories: Cardiovascular
Specialties: Cardiology, Pharmocotherapy
Topics: Heart Failure